2026-03-06T17:47:20-06:00 2025-06-30 430765316 RUBINBROWN LLP 7676 FORSYTH BLVD SUITE 2100 SAINT LOUIS MO 63105 990 2024-07-01 131632524 AMERICAN LUNG ASSOCIATION AMER 2177875864 55 W WACKER DRIVE 1150 CHICAGO IL 60601 LAURA SCOTT CFO 2177875864 2026-03-06 1 0 KIMBERLY A RYAN P00829977 3142903300 2024 2025-03-06 01:10:19Z HAROLD WIMMER 55 W WACKER DRIVE 1150 CHICAGO IL 60601 159826830 0 X WWW.LUNG.ORG X 1918 ME THE MISSION OF THE ALA IS TO SAVE LIVES BY IMPROVING LUNG HEALTH AND PREVENTING LUNG DISEASE. 21 21 563 98988 0 0 97020213 97641210 1949551 2117027 7063670 16639792 1709889 2284200 107743323 118682229 12784781 12872936 0 0 50073138 51745939 378000 1193725 12465897 50576661 51079726 113812580 116892326 -6069257 1789903 225692916 225713097 44410317 40204543 181282599 185508554 X THE AMERICAN LUNG ASSOCIATION'S MISSION IS TO SAVE LIVES BY IMPROVING LUNG HEALTH AND PREVENTING LUNG DISEASE. WE DO THIS THROUGH EDUCATION, ADVOCACY, AND RESEARCH. 0 0 54897785 2578572 LUNG CANCER, ASTHMA, LUNG DISEASE AND TOBACCO CONTROL: AS PART OF OUR MISSION, THE AMERICAN LUNG ASSOCIATION IS COMMITTED TO SUPPORTING AND IMPROVING THE LIVES OF THE MORE THAN 35 MILLION PEOPLE LIVING WITH LUNG DISEASE - A LEADING CAUSE OF DEATH IN THE UNITED STATES. WE DO THIS BY INVESTING IN RESEARCH; ADVOCATING FOR POLICIES AND LEGISLATION THAT CHAMPION CLEAN AIR, OPTIMAL CARE AND REDUCED ACCESS TO TOBACCO PRODUCTS; AND PROVIDING PROGRAMS, RESOURCES AND SUPPORT TO HELP INDIVIDUALS LIVING WITH LUNG DISEASE AND THEIR FAMILIES TO BETTER UNDERSTAND AND MANAGE THEIR DISEASE.IN FISCAL YEAR 2025, THE AMERICAN LUNG ASSOCIATION RESEARCH INSTITUTE INVESTED $22 MILLION IN GROUNDBREAKING RESEARCH, REINFORCING OUR ROLE AS ONE OF THE NATION'S LARGEST PRIVATE FUNDERS OF LUNG HEALTH STUDIES. WE EXPANDED EDUCATIONAL PROGRAMS FOR PATIENTS, CAREGIVERS, AND HEALTHCARE PROVIDERS, AND DELIVERED TARGETED TOBACCO CESSATION INITIATIVES, INCLUDING EFFORTS TO PREVENT YOUTH TOBACCO USE AND SUPPORT CESSATION AMONG TEENS AND ADULTS. THROUGHOUT THE YEAR, WE ALSO CHAMPIONED CRITICAL HEALTHCARE AND CLEAN AIR PROTECTIONS - ADVOCATING FOR MEDICAID PRESERVATION, POLICIES AND PROGRAMS THAT LIMIT POLLUTION, AND FEDERAL FUNDING FOR LUNG DISEASE RESEARCH. IN MARCH, OUR LUNG FORCE HEROES TRAVELED TO WASHINGTON, DC, TO MEET WITH LAWMAKERS AND ADVOCATE FOR LIFESAVING COVERAGE AND SUPPORT FOR THOSE AFFECTED BY LUNG CANCER. IN NOVEMBER, WE RELEASED OUR 7TH ANNUAL "STATE OF LUNG CANCER" REPORT, HIGHLIGHTING A JUMP IN THE FIVE-YEAR LUNG CANCER SURVIVAL - TO 28.4%, AN INCREASE OF 52% OVER THE PAST DECADE. WHILE LUNG CANCER REMAINS THE DEADLIEST FORM OF CANCER, SIGNIFICANT ADVANCEMENTS IN TREATMENT AND CARE ARE HELPING PEOPLE TO LIVE LONGER AND HEALTHIER THAN EVER BEFORE. HINDERING PROGRESS, HOWEVER, ARE ONGOING GAPS IN THE RATES OF BIOMARKER TESTING - THE EVALUATION OF LUNG TUMOR TISSUE TO HELP DETERMINE AN INDIVIDUAL'S SPECIFIC TYPE OF LUNG CANCER, ALLOWING FOR PRECISE AND POTENTIALLY MORE SUCCESSFUL TREATMENT - AND LUNG CANCER SCREENING, AS HIGHLIGHTED IN THE REPORT. WE KNOW THAT IF LUNG CANCER IS CAUGHT BEFORE IT SPREADS, THE LIKELIHOOD OF SURVIVING FIVE YEARS OR MORE JUMPS TO 64%, AND THAT NEARLY ONE-QUARTER OF LUNG CANCER PATIENTS RECEIVE CHEMOTHERAPY OR RADIATION BEFORE UNDERGOING BIOMARKER TESTING. IN RESPONSE, WE CONTINUE TO EXPAND OUR PROGRAMS AND RESOURCES AIMED AT PROMOTING AWARENESS AND GREATER PARTICIPATION IN THESE LIFESAVING PROGRAMS. IN FISCAL YEAR 2025, WE LAUNCHED OUR BIOMARKER, EDUCATION, AWARENESS AND TESTING (BEAT) LUNG CANCER CAMPAIGN, AIMED AT PROMOTING THE IMPORTANCE AND VALUE OF BIOMARKER TESTING THROUGH NEW WEBSITE RESOURCES, TARGETED ADVERTISING, AND EDUCATIONAL VIDEOS. WE ALSO WORKED WITH THE AD COUNCIL TO CREATE A NEW PUBLIC SERVICE ANNOUNCEMENT (PSA), "IF YOUR LUNGS COULD TALK," HIGHLIGHTING THE IMPORTANCE OF LUNG CANCER SCREENING, ESPECIALLY AMONG INDIVIDUALS WITH A HISTORY OF TOBACCO USE. THE CAMPAIGN RESULTED IN 649,000 VISITS TO OUR WEBSITE AND 250,000 COMPLETIONS OF OUR SAVED BY THE SCAN QUIZ TO DETERMINE SCREENING ELIGIBILITY. OF THE MORE THAN 1.5 MILLION PEOPLE WHO HAVE TAKEN OUR ONLINE QUIZ, 20% LEARNED THEY QUALIFY FOR LOW- OR NO-COST SCREENING. BECAUSE CLINICAL TRIALS CAN PLAY A CRITICAL, LIFESAVING ROLE IN ENSURING OPTIMAL LUNG CANCER TREATMENT AND CARE, WE LAUNCHED AN AWARENESS, TRUST AND ACTION PROGRAM TO SPECIFICALLY PROMOTE THE IMPORTANCE AND AVAILABILITY OF CLINICAL TRIALS AMONG HISPANIC LUNG CANCER PATIENTS AND CAREGIVERS. HISPANIC INDIVIDUALS REPRESENT 19% OF THE POPULATION BUT JUST 6% OF CLINICAL TRIAL PARTICIPANTS. THE PROGRAM AIMS TO RAISE AWARENESS ABOUT CLINICAL TRIALS, ADDRESS MISCONCEPTIONS, AND EMPOWER PATIENTS AND CAREGIVERS TO ULTIMATELY IMPROVE LUNG CANCER CARE AND OUTCOMES. OUR NEW AND IMPROVED EDUCATIONAL PROGRAMS THIS YEAR INCLUDED RESOURCES AND TOOLS FOR INDIVIDUALS LIVING WITH COPD, ASTHMA, BRONCHIECTASIS, AUTOIMMUNE PULMONARY ALVEOLAR PROTEINOSIS, PULMONARY ARTERIAL HYPERTENSION AND PNEUMOCOCCAL PNEUMONIA. TO SUPPORT SCHOOL HEALTH PROFESSIONALS, WE INTRODUCED A NEW GUIDE DESIGNED TO HELP THEM SECURE AND MAINTAIN FUNDING FOR EMERGENCY STOCK ASTHMA MEDICATION. WE ALSO LAUNCHED THE LUNG-FRIENDLY ENVIRONMENTS FOR YOUTH INITIATIVE-AN ONLINE HUB PROVIDING COMPREHENSIVE STRATEGIES AND RESOURCES FOR ADDRESSING ASTHMA, TOBACCO, CLEAN AIR AND MORE IN SCHOOLS AND COMMUNITY ORGANIZATIONS. IN ADDITION, WE CONTINUED TO SUPPORT AND GROW OUR PATIENT AND CAREGIVER SUPPORT PROGRAMS. MEMBERSHIP IN OUR PATIENT & CAREGIVER NETWORK - A NATIONWIDE, ONLINE SUPPORT PROGRAM PROVIDING EDUCATION, TOOLS AND WELLNESS AND OTHER RESOURCES FOR INDIVIDUALS LIVING WITH LUNG DISEASE AND THEIR CAREGIVERS - GREW TO 18,048 MEMBERS IN FISCAL YEAR 2025, REPRESENTING ALL STATES AND PUERTO RICO, A 39% INCREASE. AND OUR 11 ONLINE SUPPORT COMMUNITIES NOW SERVE 253,697 MEMBERS NATIONWIDE, OFFERING A SAFE, WELCOMING SPACE FOR THOSE FACING LUNG CANCER, CHRONIC LUNG CONDITIONS OR TOBACCO CESSATION CHALLENGES.AS FALL APPROACHED, WE ENCOURAGED IMMUNIZATION AS A SAFE AND EFFECTIVE WAY TO REDUCE THE RISK OF SEVERE SYMPTOMS AND HOSPITALIZATIONS CAUSED BY RESPIRATORY VIRUSES - ESPECIALLY FOR THOSE MOST VULNERABLE, INCLUDING ADULTS 65 AND OLDER AND INDIVIDUALS WITH LUNG CONDITIONS OR OTHER CHRONIC ILLNESSES.OUR EFFORTS IN FISCAL YEAR 2025 INCLUDED NEW AND ONGOING CAMPAIGNS PROMOTING THE IMPORTANCE OF VACCINES FOR THE PREVENTION OF INFLUENZA, OR THE FLU, RESPIRATORY SYNCYTIAL VIRUS, OR RSV - IN ADULTS, BABIES AND YOUNG CHILDREN - AND COVID-19. OUR COMPREHENSIVE RSV IN BABIES CAMPAIGN - AIMED AT PARENTS AND SOON-TO-BE PARENTS ON HOW TO PROTECT INFANTS AND TODDLERS FROM RSV, THE LEADING CAUSE OF INFANT HOSPITALIZATION - REACHED MILLIONS OF PEOPLE.DURING FLU SEASON, WE ALSO IMPLEMENTED TARGETED OUTREACH EFFORTS IN RURAL COMMUNITIES WITH LOW INFLUENZA VACCINATION RATES - ARKANSAS, MISSISSIPPI, WEST VIRGINIA, MONTANA AND KENTUCKY - AND AMONG VULNERABLE POPULATIONS, INCLUDING HOMELESS AND LOW-INCOME INDIVIDUALS WITH TUBERCULOSIS IN GEORGIA.TOBACCO USE REMAINS THE LEADING CAUSE OF PREVENTABLE DEATH IN THIS COUNTRY. AND WHILE YOUTH TOBACCO USE HAS DECLINED TO THE LOWEST LEVEL IN 25 YEARS (WITH HELP FROM THE AMERICAN LUNG ASSOCIATION'S RELENTLESS ADVOCACY AND AWARENESS EFFORTS), THE NUMBER OF MIDDLE AND HIGH SCHOOL STUDENTS WHO USE TOBACCO PRODUCTS - 2.25 MILLION - IS STILL TOO HIGH, AS TOBACCO COMPANIES USE AGGRESSIVE MARKETING TACTICS TO APPEAL TO AND ADDICT A NEW GENERATION. OUR 23RD "STATE OF TOBACCO CONTROL" REPORT HIGHLIGHTED THE IMPORTANCE OF ONGOING FUNDING FOR TOBACCO PREVENTION AND YOUTH SMOKING PROGRAMS TO REDUCE DEATH AND DISEASE. IN THE SPRING OF 2025, WE FOLLOWED UP WITH A SECOND REPORT EXAMINING THE IMPACT OF DRAMATIC CUTS TO FEDERAL TOBACCO PROGRAMS.WHILE WE STRONGLY ADVOCATED FOR THE PRESERVATION OF THESE PROGRAMS, WE CONTINUED TO SUPPORT STATE AND LOCAL TOBACCO PREVENTION EFFORTS, HELPING INDIVIDUALS WHO WANT TO STOP SMOKING THROUGH OUR FREEDOM FROM SMOKING CLASSES AND LUNG HELPLINE AND DEVELOPING NEW PROGRAMS TO PREVENT AND REDUCE TOBACCO USE. IN FISCAL YEAR 2025, WE REMAINED COMMITTED TO EDUCATING TEACHERS, SCHOOL ADMINISTRATORS, CHILDREN, TEENS AND PARENTS ABOUT THE DANGERS OF VAPING AND TOBACCO. WITH THE AD COUNCIL, WE LAUNCHED A NEW YOUTH VAPING PREVENTION PUBLIC SERVICE CAMPAIGN, "YOU'RE THE BEST PERSON," PROVIDING A HUMOROUS LOOK AT WHY PARENTS ARE THE BEST PEOPLE TO TALK TO THEIR KIDS ABOUT THE DANGERS OF VAPING. THE CAMPAIGN DROVE MORE THAN 330,000 PEOPLE TO OUR WEBSITE RESOURCES ON YOUTH VAPING. WE ALSO LAUNCHED A NEW YOUTH TOBACCO TREATMENT PLAN, A WORKSHEET AND REFERENCE TO HELP TEENS AND YOUNG ADULTS BETTER UNDERSTAND TOBACCO-USE TRIGGERS, COPING STRATEGIES, THE BENEFITS OF QUITTING AND HOW TO GET HELP. MOST IMPORTANTLY, OUR TOBACCO PREVENTION EFFORTS ARE MAKING A DIFFERENCE: ADULT CIGARETTE USE DROPPED FROM 14.0% IN 2019 TO 9.9% IN 2024, AND E-CIGARETTE USE AMONG MIDDLE AND HIGH SCHOOL STUDENTS DECLINED FROM 20.0% IN 2019 TO 5.9% IN 2024, A 71% REDUCTION. 21514470 12872936 1011090 RESEARCH: FOR MORE THAN A CENTURY, THE AMERICAN LUNG ASSOCIATION HAS DRIVEN LUNG HEALTH ADVANCEMENTS AND INNOVATION BY SUPPORTING MEDICAL RESEARCH THAT IS HELPING PEOPLE WITH LUNG DISEASE LIVE LONGER, HEALTHIER LIVES. IN FISCAL YEAR 2025, THE AMERICAN LUNG ASSOCIATION RESEARCH INSTITUTE CONTINUED TO FUND HIGH-IMPACT, LIFESAVING RESEARCH, BRINGING TOGETHER THE BEST SCIENTIFIC MINDS TO ADDRESS CRITICAL LUNG HEALTH CHALLENGES. OUR GROWING RESEARCH INVESTMENT - $225 MILLION SINCE 2000 - HAS MADE US ONE OF THE LARGEST PRIVATE FUNDERS OF LUNG HEALTH RESEARCH IN THE UNITED STATES. IN SEPTEMBER, OUR RESEARCH AWARDS INCLUDED 139 GRANTS TO PROMISING AND ESTABLISHED SCIENTISTS WORKING ON SOLUTIONS AND TREATMENTS FOR A BROAD RANGE OF LUNG HEALTH CHALLENGES, INCLUDING THE LINK BETWEEN OBESITY AND SEVERE RESPIRATORY DISEASE, THE ROLE OF INFLAMMATION IN PULMONARY FIBROSIS, AND NEW TARGETED LUNG CANCER TREATMENTS. EACH YEAR, OUR RESEARCH INVESTMENT ALSO SUPPORTS OUR AIRWAYS CLINICAL RESEARCH CENTERS NETWORK, THE LARGEST NONPROFIT CLINICAL RESEARCH NETWORK PROVIDING ASTHMA AND COPD CLINICAL TRIALS AT PROMINENT ACADEMIC MEDICAL CENTERS, AS WELL AS INNOVATIVE INDUSTRY AND NONPROFIT PARTNERSHIPS TO ACCELERATE DISCOVERY. THIS YEAR, WE PROVIDED A $200,000 AMERICAN LUNG ASSOCIATION RESEARCH INSTITUTE GRANT TO TEXAS BIOMEDICAL RESEARCH INSTITUTE TO STUDY A UNIVERSAL, ONE-TIME VACCINE. WE ALSO REACHED A CRITICAL MILESTONE IN OUR LUNG HEALTH COHORT RESEARCH STUDY - RECRUITING NEARLY 3,000 PARTICIPANTS FOR OUR PIONEERING PROJECT WHERE WE EXPECT TO FOLLOW HEALTHY ADULTS FOR APPROXIMATELY FIVE YEARS, WITH THE GOAL OF IDENTIFYING RISK FACTORS FOR LUNG DISEASE. IN FISCAL YEAR 2025, WE ALSO CONTINUED TO SUPPORT AND FUND ORGANIZATIONS COMMITTED TO ADVANCING RESEARCH. IN FISCAL YEAR 2025, THIS INCLUDED SPONSORING COPD INET IN BOSTON - HELD FOR THE FIRST TIME IN THE UNITED STATES - BRINGING TOGETHER 100 SCIENTISTS COMMITTED TO ADVANCING COPD RESEARCH FROM THE LABORATORY TO PATIENT TREATMENT AND CARE. 22633242 1063668 ADVOCACY AND ENVIRONMENTAL:EACH YEAR, THE AMERICAN LUNG ASSOCIATION SUPPORTS POLICIES AND LEGISLATION THAT HELP EVERYONE BREATHE EASIER. THIS INCLUDES ADVOCATING FOR LAWS THAT PROTECT OUR CHILDREN FROM DEADLY AIR POLLUTION AND TOBACCO PRODUCTS, AND PROVIDING FUNDING FOR CRITICAL LUNG DISEASE RESEARCH, HEALTHCARE COVERAGE, AND TOBACCO CESSATION, ASTHMA AND OTHER VITAL HEALTH PROGRAMS.IN FISCAL YEAR 2025, WE FOUGHT VIGOROUSLY TO PRESERVE LIFESAVING FEDERAL FUNDING FOR MEDICAID, ALONG WITH TAX CREDITS AND OTHER PROGRAMS PROVIDING COVERAGE FOR MORE THAN 11 MILLION INDIVIDUALS - ALL THREATENED UNDER A PROPOSED BILL, WHICH IS NOW LAW. WE ALSO ADVOCATED AGAINST PROPOSED CUTS IN PROGRAM STAFF AND SPENDING THAT SUPPORT LUNG HEALTH.OUR ADVOCACY EFFORTS HELPED TO PRESERVE HEALTHCARE COVERAGE FOR PREVENTATIVE CARE, INCLUDING LUNG CANCER SCREENING; THE REINTRODUCTION OF THE SOAR ACT TO PROVIDE EQUITABLE ACCESS TO PORTABLE OXYGEN, ALLOWING PEOPLE TO LIVE MORE ACTIVE LIVES; AND A SUPREME COURT RULING IN FAVOR OF THE FOOD AND DRUG ADMINISTRATION PROHIBITING TOBACCO COMPANIES FROM EMPLOYING SPECIFIC MARKETING STRATEGIES TO PROMOTE CERTAIN E-CIGARETTE PRODUCTS. IN FISCAL YEAR 2025, WE HOSTED TWO ADVOCACY EVENTS. IN ADDITION TO OUR ANNUAL LUNG FORCE ADVOCACY DAY IN THE SPRING, WE HELD OUR SECOND RESPIRATORY ADVOCACY DAY IN SEPTEMBER. THIS EVENT UNITED DOZENS OF INDIVIDUALS LIVING WITH ASTHMA, COPD, PULMONARY FIBROSIS, PULMONARY ARTERIAL HYPERTENSION, AND OTHER LUNG DISEASES. THEY SHARED THEIR STORIES AND MET WITH CONGRESSIONAL REPRESENTATIVES TO ADVOCATE FOR THE PROTECTION OF HEALTHCARE COVERAGE AND INCREASED FUNDING FOR RESEARCH AND VITAL PROGRAMS THAT SUPPORT THOSE AFFECTED BY RESPIRATORY CONDITIONS. THROUGHOUT THE YEAR, WE ALSO ADVOCATED FOR POLICIES AND PROGRAMS - AND THE PROTECTION OF STAFF AND FUNDING AT THE ENVIRONMENTAL PROTECTION AGENCY - TO IMPROVE THE AIR WE BREATHE. THIS INCLUDED SUPPORTING LEGISLATION TO LIMIT MERCURY AND OTHER POISONOUS EMISSIONS FROM POWER PLANTS AND OTHER POLLUTION SOURCES AND PROTECTING ENERGY EFFICIENCY PROGRAMS AND CLEAN CAR AND TRUCK WAVERS. ACCORDING TO OUR 26TH ANNUAL "STATE OF THE AIR" (SOTA) REPORT, NEARLY HALF OF PEOPLE LIVING IN THE UNITED STATES ARE EXPOSED TO DANGEROUS AIR POLLUTION LEVELS, WITH 156 MILLION PEOPLE (25 MILLION MORE THAN THE PREVIOUS YEAR) LIVING IN AREAS THAT RECEIVED AN "F" GRADE FOR OZONE OR PARTICLE POLLUTION. IN ADDITION, WE PUBLISHED TWO SUPPLEMENTAL REPORTS PROVIDING CRITICAL INSIGHTS ON HOW SATELLITE TECHNOLOGY AND OTHER INNOVATIVE SOLUTIONS CAN IMPROVE THE DETECTION OF PARTICLE POLLUTION AND NITROGEN DIOXIDE HOT SPOTS - KEY STEPS TO IMPROVING AIR QUALITY. TO SUPPORT INDIVIDUALS LIVING WITH LUNG DISEASES IN COMMUNITIES DISPROPORTIONATELY IMPACTED BY PARTICLE AND OZONE POLLUTION, WE DEVELOPED A NEW PROGRAM IN PARTNERSHIP WITH THE CVS FOUNDATION. THROUGH THIS PROJECT, WE DISTRIBUTED 346 AIR QUALITY SENSORS TO HEALTHCARE ORGANIZATIONS AND PEOPLE IN PHOENIX. DEVASTATING WILDFIRES CONTINUED TO THREATEN AIR QUALITY THROUGHOUT THE YEAR. IN JANUARY, HIGH WINDS AND DRY CONDITIONS FUELED THE SPREAD OF DEVASTATING WILDFIRES THROUGHOUT LOS ANGELES COUNTY, DESTROYING MORE THAN 12,000 HOMES, BUSINESSES, SCHOOLS AND OTHER STRUCTURES. FORTUNATELY, WE WERE ABLE TO SWIFTLY DISSEMINATE ESSENTIAL INFORMATION AND RESOURCES - THROUGH OUR WEBSITE, SOCIAL MEDIA AND MEDIA INTERVIEWS WITH OUR EXPERTS - TO HELP SAFEGUARD INDIVIDUALS AND FAMILIES, PARTICULARLY THOSE LIVING WITH ASTHMA AND OTHER CHRONIC LUNG CONDITIONS, FROM SMOKE AND OTHER SOURCES OF AIR POLLUTION. THROUGH OUR STRATEGIC PARTNERSHIPS WITH INDUSTRY LEADERS AND VOLUNTEERS WE WERE ABLE TO SECURE AND DISTRIBUTE INDUSTRIAL-GRADE AND IN-HOME AIR PURIFIERS, N-95 MASKS AND OTHER SUPPLIES TO INDIVIDUALS LIVING WITH LUNG DISEASE, SCHOOLS AND COMMUNITY ORGANIZATIONS. WE ALSO FORGED MEANINGFUL, SUSTAINABLE PARTNERSHIPS THAT PROMOTE ONGOING REBUILDING AND RESILIENCE IN THE WILDFIRE-IMPACTED COMMUNITIES THROUGHOUT SOUTHERN CALIFORNIA. AS WILDFIRES ARE AN ONGOING CHALLENGE THROUGHOUT NORTH AMERICA, WE RENEWED OUR PARTNERSHIP WITH THE CANADIAN LUNG ASSOCIATION TO HELP RAISE AWARENESS ABOUT THE HEALTH RISKS ASSOCIATED WITH WILDFIRE SMOKE. WE ALSO DEEPENED OUR COMMITMENT TO INDOOR AIR IN FISCAL YEAR 2025, BY SECURING ENVIRONMENTAL PROTECTION AGENCY (EPA) FUNDING TO LAUNCH THE CLEAN AIR SCHOOL CHALLENGE, A MULTI-YEAR CAMPAIGN EMPOWERING K-12 SCHOOLS TO IMPROVE THE QUALITY OF THEIR AIR. WE ALSO AWARDED OUR INAUGURAL INDOOR AIR RESEARCH AWARD TO A GROUNDBREAKING RESEARCHER STUDYING THE HEALTH EFFECTS OF INDOOR AIR ON MATERNAL AND CHILD HEALTH. 99045497 1 1 0 1 0 0 0 0 0 1 1 0 0 1 1 1 1 0 0 0 0 0 0 1 1 0 0 1 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 489 0 1 563 1 0 0 0 0 0 1 1 0 0 0 0 0 0 X 21 21 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 AL AK AZ AR CA CO CT DC FL GA HI IL KS KY ME MD MA MI MN MS NH NJ NM NY NC ND OH OK OR PA RI SC TN VA WA WV WI X X LAURA SCOTT CFO 2177875864 3000 KELLY LANE SPRINGFIELD IL 62711 DAVID G HILL MD CHAIR 2.00 X X 0 0 0 MICHAEL V CARSTENS CHAIR-ELECT 2.00 X X 0 0 0 CHERYL A CALHOUN CPA MBA PAST CHAIR 2.00 X X 0 0 0 MARK C JOHNSON CFA MBA SECRETARY/TREASURER 2.00 X X 0 0 0 JULIAN COY DIRECTOR 2.00 X 0 0 0 ANNE E DIXON MD DIRECTOR 2.00 X 0 0 0 AFIF EL-HASAN MD DIRECTOR 2.00 X 0 0 0 VIN GUPTA MD MPA DIRECTOR 2.00 X 0 0 0 JOY KLEINMAIER DIRECTOR 2.00 X 0 0 0 WENDY LAWSON MPH RRT DIRECTOR 2.00 X 0 0 0 COLLEEN M MCINTOSH JD LLM DIRECTOR 2.00 X 0 0 0 JUANITA MORA MD DIRECTOR 2.00 X 0 0 0 SEAN R MULDOON MD MPH FCCP DIRECTOR 2.00 X 0 0 0 JOE OCHIPINTI DIRECTOR 2.00 X 0 0 0 SUSAN B PADERNACHT EDD PCC DIRECTOR 2.00 X 0 0 0 CLAUDE A ROBINSON JR DIRECTOR 2.00 X 0 0 0 JONATHON K ROSEN BA DIRECTOR 2.00 X 0 0 0 LAURIE M SHELBY MA DIRECTOR 2.00 X 0 0 0 JOHNNY A SMITH JR MA DIRECTOR 2.00 X 0 0 0 MICHELLE SYLVIA SPRIGGS CPA DIRECTOR 2.00 X 0 0 0 STERLING QL YEE MBA DIRECTOR 2.00 X 0 0 0 HAROLD WIMMER PRESIDENT & CEO 40.00 X 815480 0 73775 LAURA SCOTT CHIEF FINANCIAL OFFICER 40.00 X 323572 0 36934 DEBORAH BROWN CHIEF MISSION OFFICER 40.00 X 302882 0 50683 SUE SWAN CHIEF DEVELOPMENT OFFICER 40.00 X 302882 0 49026 JEFF SEYLER CHIEF FIELD OFFICER 40.00 X 288377 0 47418 SARAH KRIKORIAN CHIEF HUMAN RESOURCES OFFICER 40.00 X 287572 0 47033 JOENELL HENRY-TANNER CHIEF OF STAFF, SVP GOVERNANCE 40.00 X 282472 0 16980 STACY DILLING CHIEF MARKETING OFFICER 40.00 X 270265 0 14199 ANITA ORUCHE CHIEF INCLUSION & ENGAGEMENT OFFICER 40.00 X 216265 0 22342 NEIL BALLENTINE CHIEF TECHNOLOGY OFFICER 40.00 X 212722 0 40127 PAUL BILLINGS NATIONAL SENIOR VP, PUBLIC POLICY 40.00 X 216672 0 29752 ALLISON HICKEY EXECUTIVE VP, MOUNTAIN PACIFIC & CA 40.00 X 219457 0 30226 SUSAN RAPPAPORT NATIONAL VP, RESEARCH 40.00 X 201883 0 36457 EMILY MURPHY DIVISION SENIOR VP, DEVELOPMENT 40.00 X 189331 0 36782 SOPHIE REEDS VICE PRESIDENT, DIGITAL MARKETING 40.00 X 184550 0 14257 4314382 0 545991 109 0 1 0 PRODUCTION SOLUTIONS 1953 GALLOWS RD SUITE 500 VIENNA VA 22182 MARKETING 3288700 INNOVAIRREBRICKMILL MARKETING SERVICES 2 EXECUTIVE CAMPUS SUITE 200 CHERRY HILL NJ 08002 MARKETING 2486823 RR DONNELLEY 35 W WACKER DRIVE CHICAGO IL 60601 MARKETING 1956995 RESCUE AGENCY PUBLIC BENEFIT LLC 2437 MORENA BLVD SAN DIEGO CA 92110 MARKETING 1716219 INTERACTIVE STRATEGIES 1133 CONNECTICUT AVE NW SUITE 600 WASHINGTON DC 20036 MARKETING 1284320 74 15461781 32194720 49984709 181990 97641210 PROGRAM PARTICIPANT FEE 541900 1496343 1496343 PROGRAM SERVICE CONTRACTS 541900 594933 594933 MEMBERSHIP DUES 541900 25751 25751 2117027 5282166 5282166 1174294 1174294 137035 0 137035 137035 137035 46614368 2234710 37048852 442600 9565516 1792110 11357626 11357626 2089717 15461781 3653149 -1563432 -1563432 RESEARCH GRANT SERVICE FEE 541900 2021228 2021228 515075 515075 2536303 118682229 4653330 0 16387689 X 12872936 12872936 3616922 3182889 108509 325524 36944436 31700059 704595 4539782 2922732 2504041 56819 361872 5424544 4653962 108409 662173 2837305 2435902 57451 343952 1193725 1193725 93454 93454 29809231 28312057 494426 1002748 1929591 1447789 14 481788 1108377 864011 48817 195549 2875084 2273482 229372 372230 1197725 1109020 15672 73033 154808 131837 11704 11267 305988 305988 445807 346512 41027 58268 DIRECT MAIL 9624654 6599211 432735 2592708 MISCELLANEOUS 3291743 432737 2669761 189245 POSTAGE & SHIPPING 125497 90823 1942 32732 PRINTING 117767 88229 237 29301 116892326 99045497 5380932 12465897 X 10818379 6599211 432735 3786433 388273 535476 13624344 19336458 15873955 11315435 69333 119973 2098381 1761748 16108589 8037448 8792576 8071141 140472615 139627148 44373439 44945718 225692916 225713097 12028062 11518764 12728843 12192193 7889016 6539793 11764396 9953793 44410317 40204543 X 128984881 132501521 52297718 53007033 181282599 185508554 225692916 225713097 X 1789903 422139 2013913 X X 0 1 X 1 1 1 X 83540236 112291164 100309671 97020213 97641210 490802494 83540236 112291164 100309671 97020213 97641210 490802494 490802494 4656339 8400917 6512649 6477669 6593495 32641069 311677 311677 523755240 26033731 0.93710 0.93810 X SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME: MISCELLANEOUS INCOME - 2020 AMOUNT: $ 311,677. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 1 1 1 491042 1 6639 1 49730 1 29375 1 606917 1 40294 0 1223997 0 PART II-B, LINE 1: THE AMERICAN LUNG ASSOCIATION VOLUNTEERS AND STAFF ENGAGE IN A WIDE RANGE OF ADVOCACY ACTIVITIES TO FURTHER OUR MISSION TO SAVE LIVES BY IMPROVING LUNG HEALTH AND PREVENTING LUNG DISEASE. OUR WORK INCLUDES EFFORTS TO EDUCATE ELECTED OFFICIALS, THEIR STAFF AND THE PUBLIC ON LUNG HEALTH ISSUES AND ACCESS TO HEALTHCARE. WE ADVOCATE FOR CLEAN, HEALTHY AIR TO REDUCE THE HEALTH IMPACTS OF AIR POLLUTION. WE FOCUS ON SUPPORTING THE IMPLEMENTATION AND STRENGTHENING OF THE NATION'S CLEAN AIR LAWS. WE STRONGLY SUPPORT THE PUBLIC HEALTH INFRASTRUCTURE AND LUNG HEALTH RESEARCH FUNDING INCLUDING FUNDING FOR LUNG CANCER, CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), ASTHMA, TUBERCULOSIS AND OTHER LUNG DISEASES. FURTHERMORE, THE AMERICAN LUNG ASSOCIATION VOLUNTEERS AND STAFF ACTIVELY ADVOCATE AT THE NATIONAL, STATE AND LOCAL LEVELS FOR TOBACCO CONTROL LAWS, INCLUDING EFFORTS TO REGULATE TOBACCO PRODUCTS INCLUDING E-CIGARETTES, PROMOTE TOBACCO CESSATION AND ELIMINATE EXPOSURE TO SECONDHAND SMOKE. 9349692 42051 656528 562892 9485379 9104563 56000 734541 545412 9349692 7970231 1005405 648658 519731 9104563 9016928 5300 -952335 99662 7970231 8600852 5000 1326442 915366 9016928 1.00000 0 0 2416848 2416848 10262771 4743783 5518988 461746 366836 94910 2967224 2926829 40395 8071141 BENEFICIAL INTEREST IN PERPETUAL TRUSTS 40122498 AMOUNTS HELD ON BEHALF OF OTHERS 1149081 REFUNDABLE DEPOSITS 227963 RIGHT-OF-USE-ASSETS 3446176 44945718 AMOUNTS HELD ON BEHALF OF OTHERS 1149081 ANNUITY FUND INVESTMENTS 685153 LEASE LIABILITIES 3710839 OTHER LIABILITIES 13351 PENSION & LIFE INSURANCE BENEFITS 4395369 9953793 X 175170192 422139 54145365 2013913 56581417 118588775 93454 93454 118682229 170944237 54145365 54145365 116798872 93454 93454 116892326 PART V, LINE 4: PROCEEDS EARNED FROM THE CORPUS OF THESE NUMEROUS ENDOWMENT FUNDS MAY BE EXPENDED FOR RESEARCH, RESEARCH FELLOWSHIPS, LUNG-HEALTH EDUCATION, CONTINUING MEDICAL EDUCATION LECTURES, SCHOLARSHIPS, PATIENT ASSISTANCE, ADVOCACY, TOBACCO CESSATION ASSISTANCE, AND GENERAL OPERATIONS IN ACCORDANCE WITH DONOR STIPULATIONS. PART X, LINE 2: THE ASSOCIATION IS DESIGNATED AS A NON-PROFIT ORGANIZATION AND IS EXEMPT FROM INCOME TAXES UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE. IT HAS BEEN CLASSIFIED AS AN ORGANIZATION THAT IS NOT A PRIVATE FOUNDATION. THEREFORE, CHARITABLE CONTRIBUTIONS ARE TAX DEDUCTIBLE. PART XI, LINE 2D - OTHER ADJUSTMENTS: CHANGE IN FAIR VALUE OF BENEFICIAL INTEREST IN TRUSTS 2,281,404. CHANGE IN VALUE OF SPLIT-INTEREST TRUSTS 28,593. PENSION AND POSTRETIREMENT PLAN CHANGES -296,084. X X X 1 NNE MARKETING 1666 MASSACHUSETTS AVE SUITE 14 LEXINGTON MA 02420 DIRECT MARKETING 0 13835820 387000 13448820 PERSONAL FUNDRAISING SERVICES 10 S RIVERSIDE PLAZA STE 875 CHICAGO IL 60606 DIRECT MARKETING 0 566140 613545 -47405 GLOBAL FACES DIRECT 16905 NORTHCROSS DRIVE STE 109 HUNTERSVILLE NC 28078 DIRECT MARKETING 0 67155 193180 -126025 14469115 1193725 13275390 AL AK AZ AR CA CO CT DE FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA RI SC SD TN TX UT VT VA WA WV WI WY DC FIGHT FOR AIR CLIMB 6577773 6577773 53213 154248 51773 18509 457374 LUNG FORCE WALKS 2425246 2425246 8312 99072 20583 9396 227608 70 8548479 6458762 2089717 139894 573388 697586 45164 1097029 17551498 15461781 2089717 201419 826708 769942 73069 1782011 3653149 -1563432 SCHEDULE G, PART I, LINE 2B, COLUMN (V) THE AMERICAN LUNG ASSOCIATION ACQUIRES CONTRIBUTIONS FROM DIRECT MAIL AND TELEMARKETING SERVICES. IN ORDER TO MANAGE THESE ACTIVITIES, THE AMERICAN LUNG ASSOCIATION CONTRACTS WITH PROFESSIONAL FUNDRAISERS TO DEVELOP FUNDRAISING STRATEGIES ON THESE INITIATIVES. 1 AMERICAN THORACIC SOCIETY INC 25 BROADWAY 4TH FL NEW YORK NY 10004 061548706 501(C)(3) 160001 0 RESEARCH AMERICAN COLLEGE OF CHEST PHYSICIANS 2595 PATRIOT BLVD GLENVIEW IL 60026 362170783 501(C)(3) 60000 0 RESEARCH BAYLOR COLLEGE OF MEDICINE ONE BAYLOR PLAZA HOUSTON TX 770303411 741613878 501(C)(3) 208030 0 RESEARCH BETH ISRAEL DEACONESS MEDICAL CENTER 330 BROOKLINE AVE BOSTON MA 02215 042103881 501(C)(3) 100000 0 RESEARCH BOSTON CHILDREN'S HOSPITAL 300 LONGWOOD AVENUE BOSTON MA 02115 042774441 501(C)(3) 350000 0 RESEARCH BRIGHAM AND WOMEN'S HOSPITAL INC 75 FRANCIS STREET BOSTON MA 02115 042312909 501(C)(3) 350000 0 RESEARCH COLUMBIA UNIVERSITY 615 WEST 131ST STREET NEW YORK NY 10027 135598093 501(C)(3) 200000 0 RESEARCH DELFI DIAGNOSTICS 1810 EMBARCADERO ROAD SUITE 100 PALO ALTO CA 94303 831219756 75000 0 RESEARCH DUKE UNIVERSITY BOX 104132 DURHAM NC 27708 560532129 501(C)(3) 461793 0 RESEARCH H LEE MOFFITT CANCER CENTER & RESEARCH INSTITUTE INC 12902 MAGNOLIA DRIVE TAMPA FL 33612 592451713 501(C)(3) 100000 0 RESEARCH ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI ONE GUSTAVE L LEVY PLACE BOX 3500 NEW YORK NY 100296574 136171197 501(C)(3) 500000 0 RESEARCH INDIANA UNIVERSITY 1024 E 3RD STREET ROOM 132 BLOOMINGTON IN 47405 356001673 STATE OF IN 100000 0 RESEARCH JOHNS HOPKINS UNIVERSITY 3910 KESWICH RD N4 327-B BALTIMORE MD 21211 520595110 501(C)(3) 825000 0 RESEARCH MASSACHUSETTS GENERAL HOSPITAL 55 FRUIT STREET BOSTON MA 02114 041564655 501(C)(3) 100000 0 RESEARCH MEMORIAL SLOAN KETTERING CANCER CENTER 1275 YORK AVENUE NEW YORK NY 10065 131924236 501(C)(3) 400000 0 RESEARCH MICHIGAN STATE UNIVERSITY 426 AUDITORIUM ROAD ROOM 360 EAST LANSING MI 48824 386005984 501(C)(3) 200000 0 RESEARCH NATIONAL INSTITUTE OF HEALTH DHHS 9000 ROCKVILLE PIKE BETHESDA MD 20892 520858115 GOV 100000 0 RESEARCH NATIONAL JEWISH MEDICAL AND RESEARCH CENTER 1400 JACKSON STREET DENVER CO 80206 742044647 501(C)(3) 288015 0 RESEARCH NEMOURS CHILDREN CLINIC 10140 CENTURION PARKWAY NORTH JACKSONVILLE FL 32256 590634433 501(C)(3) 474465 0 RESEARCH NEW YORK UNIVERSITY SCHOOL OF MEDICINE 550 FIRST AVENUE NEW YORK NY 10016 135562308 501(C)(3) 200000 0 RESEARCH NORTHWESTERN UNIVERSITY 619 CLARK STREET EVANSTON IL 60208 362167817 501(C)(3) 790907 0 RESEARCH PORTLAND STATE UNIVERSITY PO BOX 751 PORTLAND OR 97207 PORTLAND OR 97207 364776757 STATE OF OR 300000 0 RESEARCH PREVENT CANCER FOUNDATION 333 JOHN CARLYLE STREET SUITE 635 ALEXANDRIA VA 22314 521429544 501(C)(3) 25000 0 RESEARCH PURDUE UNIVERSITY 2550 NORTHWESTERN AVE SUITE 1100 WEST LAFAYETTE IN 47906 356002041 STATE OF IN 150000 0 RESEARCH REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN FRANCISCO 1855 FOLSOM STREET SAN FRANCISCO CA 94143 946036493 STATE OF CA 287620 0 RESEARCH RUTGERS THE STATE UNIVERSITY C/O TAX OFFICE 33 KNIGHTSBRIDGE ROAD ROO C281 PISCATAWAY NJ 08854 226001086 STATE OF NJ 200000 0 RESEARCH SEATTLE BIOMEDICAL RESEARCH INSTITUTE 307 WESTLAKE AVENUE SEATTLE WA 98109 911452438 501(C)(3) 135000 0 RESEARCH STATE UNIVERSITY OF IOWA 105 JESSUP HALL IOWA CITY IA 52242 426004813 STATE OF IA 100000 0 RESEARCH TEMPLE UNIVERSITY 1852 N 10TH STREET PHILADELPHIA PA 19122 231365971 501(C)(3) 317874 0 RESEARCH TEXAS BIOMEDICAL RESEARCH INSTITUTE 8715 W MILITARY DRIVE SAN ANTONIO TX 78227 741109630 501(C)(3) 400000 0 RESEARCH THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS - CHICAGO 809 S MARSHFIELD AVE M/C 551 CHICAGO IL 606127502 376000511 501(C)(3) 250000 0 RESEARCH THE BOARD OF TRUSTEES OF THE UNIVERISTY OF ILLINOIS 809 S MARSHFIELD AVE M/C 551 CHICAGO IL 606127502 376000511 501(C)(3) 300000 0 RESEARCH THE BROAD INSTITUTE 415 MAIN ST CAMBRIDGE MA 02142 263428781 501(C)(3) 100000 0 RESEARCH THE MEDICAL COLLEGE OF WISCONSIN INC 8701 WATERTOWN PLANK RD MILWAUKEE WI 53226 390806261 501(C)(3) 200000 0 RESEARCH THE OHIO STATE UNIVERSITY 901 WOODY HAYES DR 2020 BLANKENSHIP HALL COLUMBUS OH 43210 316025986 STATE OF OH 150000 0 RESEARCH THE REGENTS OF THE UNIVERSITY OF CALIFORNIA LOS ANGELES 10889 WILSHIRE BLVD SUITE 700 LOS ANGELES CA 900951406 956006143 STATE OF CA 400000 0 RESEARCH THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA 3451 WALNUT STREET 5TH FLOOR FRANKLIN BUILDING PHILADELPHIA PA 19104 231352685 501(C)(3) 100000 0 RESEARCH UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL 104 AIRPORT DRIVE SUITE 2200 CHAPEL HILL NC 25799 566001393 501(C)(3) 300000 0 RESEARCH UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON 301 UNIVERSITY BLVD GALVESTON TX 775551166 746000949 STATE OF TX 200000 0 RESEARCH UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER 5323 HARRY HINES BLVD MC9029 DALLAS TX 75390 756002868 STATE OF TX 200000 0 RESEARCH THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY 3601 SPRUCE STREET PHILADELPHIA PA 19104 236434390 501(C)(3) 200000 0 RESEARCH TRUSTEES OF BOSTON UNIVERSITY 881 COMMONWEALTH AVENUE BOSTON MA 02215 042103547 501(C)(3) 600000 0 RESEARCH TRUSTEES OF TUFTS COLLEGE 80 GEORGE STREET MEDFORD MA 02155 042103634 501(C)(3) 100000 0 RESEARCH UNIVERSITY OF ALABAMA AT BIRMINGHAM UNIVERSITY STATION BIRMINGHAM AL 35294 636005396 STATE OF AL 324415 0 RESEARCH UNIVERSITY OF ARIZONA PO BOX 3308 TUCSON AZ 85722 742652689 501(C)(3) 289565 0 RESEARCH UNIVERSITY OF COLORADO DENVER MS F428 BLDG 500 13001 E 17TH AURORA CO 80045 846000555 STATE OF CO 150000 0 RESEARCH UNIVERSITY OF KANSAS CENTER FOR RESEARCH 2385 IRVING HILL ROAD LAWRENCE KS 66045 480680117 501(C)(3) 467495 0 RESEARCH UNIVERSITY OF MICHIGAN 5082 WOLVERINE TOWER 3003 S STATE STREET ANN ARBOR MI 48109 386006309 STATE OF MI 295532 0 RESEARCH UNIVERSITY OF VERMONT 85 SOUTH PROSPECT STREET BURLINGTON VT 05405 030179440 501(C)(3) 323130 0 RESEARCH VANDERBILT UNIVERSITY MEDICAL CENTER 1161 21ST AVENUE SOUTH D-3300 MEDICAL CENTER NORTH NASHVILLE TN 37232 352528741 501(C)(3) 350000 0 RESEARCH WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY PO BOX 22371 NEW YORK NY 100872371 131623978 501(C)(3) 201085 0 RESEARCH RETURNED FUNDS & CANCELLED PAYMENTS - VARIOUS UNIVERSITIES 55 W WACKER DR CHICAGO IL 60601 131632524 501(C)(3) -586991 0 RESEARCH 50 1 PART I, LINE 2: AWARD RECIPIENTS ARE REQUIRED TO SUBMIT A RENEWAL APPLICATION AFTER THEIR FIRST YEAR OF FUNDING. RENEWAL APPLICATIONS ARE THEN REVIEWED BY OUR RESEARCH COMMITTEE CHAIRS FOR APPROVAL OF SECOND YEAR FUNDING. AT THE TIME OF TERMINATION (AFTER THE SECOND YEAR OF FUNDING), AWARD RECIPIENTS ARE REQUIRED TO SUBMIT A SUMMARY OF THEIR ACTIVITIES, COPIES OF PRESENTATIONS AND/OR PUBLICATIONS, AND A CASH DISBURSEMENT REPORT FOR THE ENTIRE GRANT TIME. X X X X X X 0 1 0 0 0 0 0 0 0 HAROLD WIMMER PRESIDENT & CEO 592872 0 65000 0 157608 0 39917 0 33858 0 889255 0 0 0 LAURA SCOTT CHIEF FINANCIAL OFFICER 295572 0 28000 0 0 0 34879 0 2055 0 360506 0 0 0 DEBORAH BROWN CHIEF MISSION OFFICER 280882 0 22000 0 0 0 35746 0 14937 0 353565 0 0 0 SUE SWAN CHIEF DEVELOPMENT OFFICER 280882 0 22000 0 0 0 35746 0 13280 0 351908 0 0 0 JEFF SEYLER CHIEF FIELD OFFICER 278377 0 10000 0 0 0 34766 0 12652 0 335795 0 0 0 SARAH KRIKORIAN CHIEF HUMAN RESOURCES OFFICER 265572 0 22000 0 0 0 22512 0 24521 0 334605 0 0 0 JOENELL HENRY-TANNER CHIEF OF STAFF, SVP GOVERNANCE 260472 0 22000 0 0 0 15071 0 1909 0 299452 0 0 0 STACY DILLING CHIEF MARKETING OFFICER 250265 0 20000 0 0 0 12941 0 1258 0 284464 0 0 0 NEIL BALLENTINE CHIEF TECHNOLOGY OFFICER 212722 0 0 0 0 0 26385 0 13742 0 252849 0 0 0 ALLISON HICKEY EXECUTIVE VP, MOUNTAIN PACIFIC & CA 219457 0 0 0 0 0 17500 0 12726 0 249683 0 0 0 PAUL BILLINGS NATIONAL SENIOR VP, PUBLIC POLICY 213672 0 3000 0 0 0 27878 0 1874 0 246424 0 0 0 ANITA ORUCHE CHIEF INCLUSION & ENGAGEMENT OFFICER 199265 0 17000 0 0 0 9923 0 12419 0 238607 0 0 0 SUSAN RAPPAPORT NATIONAL VP, RESEARCH 201883 0 0 0 0 0 24882 0 11575 0 238340 0 0 0 EMILY MURPHY DIVISION SENIOR VP, DEVELOPMENT 186331 0 3000 0 0 0 20868 0 15914 0 226113 0 0 0 SOPHIE REEDS VICE PRESIDENT, DIGITAL MARKETING 181550 0 3000 0 0 0 12880 0 1377 0 198807 0 0 0 PART I, LINE 4B & PART II: THE PRESIDENT AND CEO'S 2024 REPORTED COMPENSATION IS HIGHER DUE TO THE VESTING OF A MULTI-YEAR DEFERRED COMPENSATION ARRANGEMENT UNDER A 457(F) PLAN OF $157,608. X SUPPLIES 107 181990 FMV 0 1 0 FORM 990, PART VI, SECTION A, LINE 1A EXECUTIVE COMMITTEE: THE EXECUTIVE COMMITTEE SHALL ACT IN PLACE OF AND WITH THE FULL AUTHORITY OF THE BOARD OF DIRECTORS WHEN THE BOARD OF DIRECTORS IS NOT IN SESSION, SUBJECT TO THE BOARD'S POWER TO AMEND OR CHANGE THOSE ACTIONS WHICH HAVE NOT BEEN IMPLEMENTED PRIOR TO THE BOARD MEETING OR MEETINGS FOLLOWING THE EXECUTIVE MEETING AT WHICH SUCH ACTION WAS TAKEN. THE BOARD OF DIRECTORS HAS THE POWER TO AUTHORIZE AND DELEGATE TO THE EXECUTIVE COMMITTEE TO THE EXTENT PERMITTED BY THE ASSOCIATION'S BYLAWS AND APPLICABLE LAW. THE EXECUTIVE COMMITTEE SHALL NOT HAVE THE AUTHORITY TO APPOINT OFFICERS EXCEPT ON AN INTERIM BASIS TO FILL A VACANCY, ENTER INTO OR AMEND CONTRACTS WITH OFFICERS, AMEND THE POLICIES MANUAL, OR BORROW MONEY IN EXCESS OF THE AMOUNTS EXPRESSLY AUTHORIZED BY THE BOARD. THE EXECUTIVE COMMITTEE SHALL HAVE NO AUTHORITY TO AMEND THE ARTICLES OF INCORPORATION, ADOPT A PLAN OF MERGER OR CONSOLIDATION, AUTHORIZE THE SALE OR OTHER DISPOSITION OF ALL OR SUBSTANTAILLY ALL OF THE PROPERTY AND ASSETS OF THE ASSOCIATION, AUTHORIZE THE VOLUNTARY DISSOLUTION OF THE ASSOCIATION OR REVOCATION OF SUCH DISSOLUTION, OR AMEND THE BYLAWS OF THE ASSOCIATION. THE EXECUTIVE COMMITTEE MAY ESTABLISH A LEADERSHIP SUBCOMMITTEE CONSISTING OF THE CHAIR, VICE-CHAIR, AND PAST-CHAIR, WHICH SHALL SERVE AS THE EXECUTIVE COMMITTEE'S LIAISON TO THE PRESIDENT AND CEO. THE GOVERNANCE COMMITTEE SHALL PRESENT ANNUALLY TO THE BOARD OF DIRECTORS ITS RECOMMENDED NOMINEES FOR MEMBERS OF THE BOARD OF DIRECTORS, MEMBERS OF THE GOVERNANCE COMMITTEE AND OFFICERS (OTHER THAN THE PRESIDENT AND CHIEF EXECUTIVE OFFICER) OF THE ASSOCIATION (INCLUDING A RECOMMENDATION WHERE APPROPRIATE, FOR THE DESIGNATION OF THE VICE-CHAIR AS CHAIR-ELECT). OTHER NOMINATIONS MAY NOT BE MADE AT THE MEETING OF THE BOARD OF DIRECTORS FROM THE FLOOR. FORM 990, PART VI, SECTION B, LINE 11B AMERICAN LUNG ASSOCIATION HAS ESTABLISHED THE FOLLOWING REVIEW PROCESS TO ENSURE THAT THE INFORMATION REPORTED IS COMPLETE AND ACCURATE. FORM 990 IS PREPARED BY AN OUTSIDE ACCOUNTING FIRM AND REVIEWED BY THE CFO. PRIOR TO ELECTRONIC SUBMISSION, IT IS REVIEWED BY THE ORGANIZATION'S DELEGATED RESPONSIBLE BODY, THE AUDIT AND RISK OVERSIGHT COMMITTEE, FOR APPROVAL. AFTER APPROVAL BY THE AROC COMMITTEE, THE MEMBERS OF THE GOVERNING BODY REVIEW THE FORM PRIOR TO SUBMISSION. ALL COMMENTS ARE DOCUMENTED, ADDRESSED AND FINALIZED BEFORE SUBMISSION. FORM 990, PART VI, SECTION B, LINE 12C ALA CURRENTLY HAS IN PLACE A CONFLICT OF INTEREST POLICY WHICH IT MONITORS AND ENFORCES ANNUALLY AND HAS A STANDING GOVERNANCE COMMITTEE THAT OVERSEES ITS EXECUTION. THE ORGANIZATION CURRENTLY MANDATES THAT ALL MEMBERS OF THE GOVERNING BODY, COMMITTEE MEMBERS AND ALL STAFF ANNUALLY SIGN A CONFLICT OF INTEREST POLICY AND DISCLOSE ANY POTENTIAL OR ACTUAL CONFLICTS THAT MAY EXIST. THE SIGNED CONFLICT OF INTEREST POLICY STATEMENTS ARE SUBMITTED TO THE GOVERNANCE COMMITTEE. THESE STATEMENTS ARE REVIEWED FOR POTENTIAL OR ACTUAL CONFLICTS. FORM 990, PART VI, SECTION B, LINE 15 THE AMERICAN LUNG ASSOCIATION HAS ESTABLISHED A COMPENSATION POLICY FOR ITS EXECUTIVE COMMITTEE TO FOLLOW IN ESTABLISHING THE COMPENSATION FOR ITS CEO, TOP MANAGEMENT OFFICIAL, OTHER OFFICERS OR KEY EMPLOYEES. THE POLICY MANDATES THAT EXECUTIVE COMPENSATION BE PERIODICALLY REVIEWED BY THE COMMITTEE AND THAT THE COMMITTEE SHOULD BE FREE OF CONFLICTS OF INTEREST. IN ADDITION, THE APPROVING COMMITTEE NEEDS TO REVIEW APPROPRIATE AND ADEQUATE DATA TO DETERMINE THE REASONABLENESS OF THE COMPENSATION BEING CONSIDERED. THE COMMITTEE MAY USE A VARIETY OF INFORMATION AND STUDIES THAT ARE AVAILABLE TO DETERMINE THAT THE APPROPRIATE LEVEL OF COMPENSATION IS BEING PAID TO ITS EXECUTIVES. THE COMMITTEE'S DECISION ON THE AMOUNT OF COMPENSATION PAID IS DOCUMENTED IN A CONTEMPORANEOUSLY WRITTEN FORMAT AND DOCUMENTS THE DATE OF THE DECISION, THE MEMBERS PRESENT DURING THE MEETING AND THOSE WHO VOTED ON IT. THE DETAILS OF THE TRANSACTION THAT WAS APPROVED AND THE COMPARABILITY DATA USED AND RELIED UPON TO MAKE THE DECISION. ALA CONDUCTS PERIODIC COMPENSATION REVIEW FOR THE CEO AS WELL AS OTHER OFFICERS AND KEY EMPLOYEES. FORM 990, PART VI, SECTION C, LINE 19 THE THREE MOST RECENT YEARS OF FORM 990 AND ANNUAL REPORTS ARE AVAILABLE ON AMERICAN LUNG ASSOCIATION'S WEBSITE, WWW.LUNG.ORG. GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY ARE AVAILABLE TO THE PUBLIC UPON REQUEST. OUR WEBSITE ALSO PROVIDES THE NAMES OF OUR BOARD OF DIRECTORS AND OUR ETHICS POLICY. FORM 990, PART IX, LINE 11G PROGRAM CONSULTING: PROGRAM SERVICE EXPENSES 22,446,401. TOTAL EXPENSES 22,446,401. OTHER FEES: PROGRAM SERVICE EXPENSES 5,865,656. MANAGEMENT AND GENERAL EXPENSES 494,426. FUNDRAISING EXPENSES 1,002,748. TOTAL EXPENSES 7,362,830. FORM 990, PART XI, LINE 9: CHANGE IN FAIR VALUE OF BENEFICIAL INTEREST IN TRUSTS 2,281,404. CHANGE IN VALUE OF SPLIT-INTEREST TRUSTS 28,593. PENSION AND RETIREMENT PLAN CHANGES -296,084. FORM 990, PART XII, LINE 2C: THE PROCESS HAS NOT CHANGED FROM THE PRIOR YEAR.